Michael Tolentino
Founder at Aviceda Therapeutics, Inc.
Profile
Michael Tolentino is the founder of Aviceda Therapeutics, Inc. He currently holds positions as Director at Panther Pharmaceuticals, Inc., Director at Bespoke, Inc., and Co-Chief Operating Officer & Director at Aviceda Ophthalmics, Inc.
Michael Tolentino active positions
| Companies | Position | Start |
|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Founder | - |
Panther Pharmaceuticals, Inc.
 Panther Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Panther Pharmaceuticals, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Bespoke, Inc.
 Bespoke, Inc. Packaged SoftwareTechnology Services Bespoke, Inc. sells eyewear and provides assistance to retailers and eyewear brands to improve and expand their reach in the industry. The private company is based in San Francisco, CA. The company offers a virtual try-on feature and precise frame and lens measurements through their scan technology. The company aims to help both in-store and online businesses improve their customer experience and reduce return rates. The company was founded by Eric Varady, who has been the CEO since incorporation. | Director/Board Member | - |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Panther Pharmaceuticals, Inc.
Panther Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Panther Pharmaceuticals, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Bespoke, Inc.
Bespoke, Inc. Packaged SoftwareTechnology Services Bespoke, Inc. sells eyewear and provides assistance to retailers and eyewear brands to improve and expand their reach in the industry. The private company is based in San Francisco, CA. The company offers a virtual try-on feature and precise frame and lens measurements through their scan technology. The company aims to help both in-store and online businesses improve their customer experience and reduce return rates. The company was founded by Eric Varady, who has been the CEO since incorporation. | Technology Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Stock Market
- Insiders
- Michael Tolentino
